Please sign in to follow a disease.
Ryvu Therapeutics Sa
Clinical trials sponsored by Ryvu Therapeutics Sa, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for Tough-to-Treat lymphoma: Two-Drug combo enters Mid-Stage trial Results expected Dec 2026 (estimated)
- Cancer drug RVU120 gets extended trial for ongoing patients Results expected Dec 2026 (estimated)
- Two-Drug combo targets leukemia that outsmarted its first treatment Results expected Aug 2027 (estimated)